Nuwellis Inc (NUWE)
Nuwellis, Inc. is a healthcare equipment company focused on medical devices for ultrafiltration therapy. Its Aquadex FlexFlow and Aquadex SmartFlow systems are designed to help treat patients with fluid overload associated with heart failure. The Aquadex FlexFlow platform includes a console, a disposable blood circuit set, and a disposable catheter. The company markets its products to hospitals and clinics in the United States through a direct sales force and works with specialty healthcare distributors in a range of international markets, including parts of Europe, Asia, Latin America, and the Middle East. Founded in 1999 and based in Eden Prairie, Minnesota, Nuwellis adopted its current name in April 2021; it was previously known as CHF Solutions, Inc.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-NUWE
|
$3.62
|
24.5% Upside
|
Undervalued
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 11, 2026
|
0.0x
|
0.1x
|
0.0x
|
252.174 K
|
-1.566 M
|
51.9%
|
62.6%
|
-159.2
|
—
|
60.4%
|
